CNS Breathe Right Near Clear translucent nasal strips to hit shelves in November.
This article was originally published in The Gray Sheet
Executive Summary
CNS "NEAR CLEAR" BREATHE RIGHT NASAL STRIPS LAUNCH is planned for November, Minneapolis-based CNS states. The translucent strips are being offered as a cosmetic alternative to the company's functionally identical beige nasal strips. Although CNS plans to boost Breathe Right's advertising spending in the fourth quarter, in step with the start of the cold season, the Near Clear strips will not receive significant separate promotion.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.